OrbiMed Capital GP VIII LLC, Director at Sionna Therapeutics, Inc. (SION), sold 1,875 shares at $44.50 ($83K) on 2025-12-17, disclosed to the SEC on 2025-12-19.
Open-market sale of $83k SION by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.50 | 900 | $40K | 48.0% |
| 2 | $44.49 | 100 | $4K | 5.3% |
| 3 | $44.49 | 875 | $39K | 46.7% |
| Total | $44.49 avg | 1,875 | $83K | 100% |
| Filing → |
| SION | BUY | 2025-02-10 | $9.9M | — | Filing → |